Pharma

Your Article Summary

See Latest Articles

Merck Wins SINGULAIR Patent Infringement Lawsuit
Merck & Co., 08/20/09

Merck and Co., Inc. announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in a patent infringement suit against Teva Pharmaceuticals USA Inc. (Teva). Teva was seeking FDA approval to sell a generic version of 4, 5 and 10 mg tablets of SINGULAIR, Merck's asthma and allergic rhinitis medicine.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Zoster vaccination: A new opportunity for adult immunization
Canadian Journal of Infectious Diseases, 12/15/09

FDA Approves Newly Revised Prescribing Information For Azilect Reducing Medication And Food Restrictions
Teva Pharmaceutical Industries, 12/15/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

 See all of Drug/Product Approvals